Marc is passionate about creating new biomedical ventures. He is a co-founder and CEO at Senolytic Therapeutics Inc., a pharmaceutical company that develops a novel class of medicines by targeting senescence cells. He also supported investments and strategic partnerships at Life Biosciences Inc. in Europe. Currently, Marc is a strategic advisor at Retinset Therapeutics, Cyclomed, Cebiotex and Origen Ventures. He is a co-founder and Partner at Chasing Science, an early-stage biomedical venture builder. Marc brings experience as advisor and board member for multiple organizations and as co-founder of several companies. Marc gained a PhD in Biochemistry from the University of Oxford in 2006, and a Harvard Business School PLD Program in 2011.